308 related articles for article (PubMed ID: 7514222)
1. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats.
Iwamoto ET; Marion L
J Pharmacol Exp Ther; 1994 May; 269(2):699-708. PubMed ID: 7514222
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats.
Iwamoto ET; Marion L
J Pharmacol Exp Ther; 1994 Nov; 271(2):601-8. PubMed ID: 7965774
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
Iwamoto ET; Marion L
J Pharmacol Exp Ther; 1993 Jul; 266(1):329-38. PubMed ID: 8101218
[TBL] [Abstract][Full Text] [Related]
4. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
5. Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.
Iwamoto ET
J Pharmacol Exp Ther; 1989 Nov; 251(2):412-21. PubMed ID: 2810106
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus.
Iwamoto ET
J Pharmacol Exp Ther; 1991 Apr; 257(1):120-33. PubMed ID: 1673472
[TBL] [Abstract][Full Text] [Related]
7. Adrenergic, serotonergic and cholinergic components of nicotinic antinociception in rats.
Iwamoto ET; Marion L
J Pharmacol Exp Ther; 1993 May; 265(2):777-89. PubMed ID: 8388459
[TBL] [Abstract][Full Text] [Related]
8. The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance.
Xu JY; Hill KP; Bidlack JM
J Pharmacol Exp Ther; 1998 Jan; 284(1):196-201. PubMed ID: 9435178
[TBL] [Abstract][Full Text] [Related]
9. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
Xu JY; Tseng LF
Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats.
McDonald CE; Gagnon MJ; Ellenberger EA; Hodges BL; Ream JK; Tousman SA; Quock RM
J Pharmacol Exp Ther; 1994 May; 269(2):601-8. PubMed ID: 8182526
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide/cyclic GMP/K(+) channel pathways in the antinociceptive effect caused by 2,3-bis(mesitylseleno)propenol.
Jesse CR; Savegnago L; Nogueira CW
Life Sci; 2007 Dec; 81(25-26):1694-702. PubMed ID: 18031763
[TBL] [Abstract][Full Text] [Related]
13. Involvement of excitatory amino acid receptors and nitric oxide in the rostral ventromedial medulla in modulating secondary hyperalgesia produced by mustard oil.
Urban MO; Coutinho SV; Gebhart GF
Pain; 1999 May; 81(1-2):45-55. PubMed ID: 10353492
[TBL] [Abstract][Full Text] [Related]
14. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat.
Thorat SN; Hammond DL
J Pharmacol Exp Ther; 1997 Dec; 283(3):1185-92. PubMed ID: 9399992
[TBL] [Abstract][Full Text] [Related]
15. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed.
McCulloch AI; Bottrill FE; Randall MD; Hiley CR
Br J Pharmacol; 1997 Apr; 120(8):1431-8. PubMed ID: 9113362
[TBL] [Abstract][Full Text] [Related]
16. Pressor response to pulsatile compression of the rostral ventrolateral medulla mediated by nitric oxide and c-fos expression.
Morimoto S; Sasaki S; Miki S; Kawa T; Itoh H; Nakata T; Takeda K; Nakagawa M
Br J Pharmacol; 2000 Mar; 129(5):859-64. PubMed ID: 10696082
[TBL] [Abstract][Full Text] [Related]
17. The antinociceptive activity of Muntingia calabura aqueous extract and the involvement of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in its observed activity in mice.
Zakaria ZA; Sulaiman MR; Jais AM; Somchit MN; Jayaraman KV; Balakhrisnan G; Abdullah FC
Fundam Clin Pharmacol; 2006 Aug; 20(4):365-72. PubMed ID: 16867020
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse.
Xu JY; Tseng LF
J Pharmacol Exp Ther; 1995 Jul; 274(1):8-16. PubMed ID: 7616452
[TBL] [Abstract][Full Text] [Related]
19. Multiple spinal mediators in parenteral nicotine-induced antinociception.
Rogers DT; Iwamoto ET
J Pharmacol Exp Ther; 1993 Oct; 267(1):341-9. PubMed ID: 7901397
[TBL] [Abstract][Full Text] [Related]
20. delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
Pacheco DF; Reis GM; Francischi JN; Castro MS; Perez AC; Duarte ID
Life Sci; 2005 Nov; 78(1):54-60. PubMed ID: 16135369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
